Prof. Pengfei Tu won the "16<sup>th</sup> China Pharmaceutical Development Award--Innovative Drug Special Contribution Award".
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 512
- Publication type:
- Article
Works matching IS 10031057 AND DT 2023 AND VI 32 AND IP 6
Results: 13
1
2
The research group of Prof. Rongsheng Zhao from Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences won the Promotion Award of China's "Management Science Award".
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 494
- Publication type:
- Article
3
The research group of Prof. Demin Zhou has made breakthroughs in the research and development of vaccines for personalized cancer treatment.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 505
- By:
- Publication type:
- Article
4
The research group of Prof. Yanxing Jia has made important progress in the field of total synthesis of natural product.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 503
- Publication type:
- Article
5
Ningbo Institute of Marine Medicine Peking University, the first off-site scientific research institution of Peking University Health Science Center, officially opened its campus.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 495
- Publication type:
- Article
6
Oyster peptide ameliorates hepatic fibrosis through the NF-κB/iNOS signaling pathway.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 435, doi. 10.5246/jcps.2023.06.037
- By:
- Publication type:
- Article
7
The research group of Prof. Tao Liu realized supramolecular regulation of tetrazine bioorthogonal reactivity.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 508
- By:
- Publication type:
- Article
8
The in vitro antioxidant activities of the ethanol extract and its different polar fractions from Ephedra saxatilis Royle ex Florin in Tibet.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 478, doi. 10.5246/jcps.2023.06.041
- By:
- Publication type:
- Article
9
Cidofovir inhibits human adenovirus type 55 infection in vitro.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 473, doi. 10.5246/jcps.2023.06.040
- By:
- Publication type:
- Article
10
Mangiferin alleviates cardiac inflammatory injury in spontaneously hypertensive rats by inhibiting the MCP-1/CCR2 signaling pathway.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 460, doi. 10.5246/jcps.2023.06.039
- By:
- Publication type:
- Article
11
Discussion on the potential target and mechanism of Dachaihu Decoction in treating hyperlipidemia based on network pharmacology.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 446, doi. 10.5246/jcps.2023.06.038
- By:
- Publication type:
- Article
12
Analysis of 365 illogical prescriptions for parenteral feeding from a hospital's intravenous drug dispensing center.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 487, doi. 10.5246/jcps.2023.06.042
- By:
- Publication type:
- Article
13
The structure and antiproliferative activity of the inclusion complex of neoandrographolide/β-cyclodextrin.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 6, p. 427, doi. 10.5246/jcps.2023.06.036
- By:
- Publication type:
- Article